Dr. Chernoff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 Bret Harte Rd
San Rafael, CA 94901Phone+1 415-459-6601Fax+1 415-459-6602
Education & Training
- University of California (San Francisco)Residency, Internal Medicine, 1981 - 1984
- New York University School of MedicineClass of 1981
Certifications & Licensure
- CA State Medical License 1983 - 2026
- UT State Medical License 2019 - 2022
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 7 citationsSafety and efficacy of ADS-5102 (amantadine) extended release capsules to improve walking in multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.Jeffrey A. Cohen, Samuel F. Hunter, Theodore R Brown, Mark Gudesblatt, Ben Thrower
Multiple Sclerosis. 2019-04-01 - 8 citationsDetermination of the minimally important difference (MID) in multi-biomarker disease activity (MBDA) test scores: impact of diurnal and daily biomarker variation patte...David Chernoff, P. Scott Eastman, C.C. Hwang, Darl D. Flake, Xingbin Wang
Clinical Rheumatology. 2019-02-01 - 20 citationsAssociation of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial.K. Hambardzumyan, Rebecca Bolce, Saedis Saevarsdottir, Kristina Forslind, Johan K. Wallman
RMD Open. 2016-03-01
Press Mentions
- Immunoautonomics: Can We Hack the Power of the Autonomic Nervous System?October 22nd, 2019
- Vagus Nerve Stimulation Wanders into Mainstream RheumatologyOctober 22nd, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: